title: Localization of mesenchymal stem cells grafted with a hyaluronan-based scaffold in the infarcted heart.
abstract: BACKGROUND
  Permanence of grafted stem cells in the infarcted myocardial area has been suggested to be favored by tissue engineering strategies, including the application of a scaffold as a cell support. However, an estimation of how many cells remain localized in the site of transplantation has never been done. The aim of this work was to investigate the localization of mesenchymal stem cells (MSCs) grafted with a well cell-adhesive polymer in the scar region of the infarcted heart.
  
  
  METHODS
  Rat MSCs were engineered in a hyaluronan-based scaffold (HYAFF(®)11) for 3 wk. The hearts of donor rats were also explanted, subjected to coronary artery ligation, and grafted into the abdomen of syngeneic rats. Two wk after coronary ligation a small dish of the HYAFF(®)11/MSC construct was introduced into a pouch created in the ventricular wall of the infarct area and left for 2 wk.
  
  
  RESULTS
  Under ex vivo conditions, MSCs tightly adhered to the hyaluronan fibers and secreted abundant extracellular matrix. In contrast, HYAFF(®)11 was not more surrounded by the engrafted MSCs 2 wk after construct transplantation. Most MSCs migrated near the border zone of the infarcted area close to the coronary vessels. Moreover, the infarcted region of the heart was enriched in capillaries and the degree of fibrosis was attenuated.
  
  
  CONCLUSIONS
  Two wk after transplantation most MSCs grafted in the infarcted myocardium with HYAFF(®)11 had left the scaffold and moved to the border zone. Nevertheless, this treatment increased the myocardial vascularization and reduced the degree of fibrosis in the scar area.
authors.affiliation: Department of Biochemistry, University of Bologna, Bologna, Italy; National Institute for Cardiovascular Research (INRC), Bologna, Italy.
authors.forename: Emanuela
authors.initials: E
authors.lastname: Fiumana
authors.forename: Gianandrea
authors.initials: G
authors.lastname: Pasquinelli
authors.forename: Laura
authors.initials: L
authors.lastname: Foroni
authors.forename: Marco
authors.initials: M
authors.lastname: Carboni
authors.forename: Francesca
authors.initials: F
authors.lastname: Bonafé
authors.forename: Catia
authors.initials: C
authors.lastname: Orrico
authors.forename: Bruno
authors.initials: B
authors.lastname: Nardo
authors.forename: Matvey
authors.initials: M
authors.lastname: Tsivian
authors.forename: Flavia
authors.initials: F
authors.lastname: Neri
authors.forename: Giorgio
authors.initials: G
authors.lastname: Arpesella
authors.forename: Carlo
authors.initials: C
authors.lastname: Guarnieri
authors.forename: Claudio M
authors.initials: CM
authors.lastname: Caldarera
authors.forename: Claudio
authors.initials: C
authors.lastname: Muscari
mesh_terms: D000818:Animals; D002448:Cell Adhesion / Q000502:physiology; D002465:Cell Movement / Q000502:physiology; D002478:Cells, Cultured; D002921:Cicatrix / Q000473:pathology; D003331:Coronary Vessels / Q000502:physiology; D004195:Disease Models, Animal; D004719:Endomyocardial Fibrosis / Q000517:prevention & control; D006820:Hyaluronic Acid; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods*; D059630:Mesenchymal Stem Cells / Q000473:pathology; D009203:Myocardial Infarction / Q000473:pathology* / Q000601:surgery*; D051381:Rats; D011917:Rats, Inbred Lew; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds; D016896:Treatment Outcome
chemical_list: D006820:Hyaluronic Acid